BindingDB logo
myBDB logout

null

SMILES: COCC1CCCCN1c1ccc(cc1)N1CCC[C@@H](NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O

InChI Key: InChIKey=SFSMUBIVKXZMIN-OZAIVSQSSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 497396   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM497396
PNG
(US11008301, Example 14)
Show SMILES COCC1CCCCN1c1ccc(cc1)N1CCC[C@@H](NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O |r|
Show InChI InChI=1S/C26H31F3N4O3/c1-36-17-22-5-2-3-15-32(22)20-11-13-21(14-12-20)33-16-4-6-23(24(33)34)31-25(35)30-19-9-7-18(8-10-19)26(27,28)29/h7-14,22-23H,2-6,15-17H2,1H3,(H2,30,31,35)/t22?,23-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 36n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair
N-formyl peptide receptor 2


(Homo sapiens (Human))
BDBM497396
PNG
(US11008301, Example 14)
Show SMILES COCC1CCCCN1c1ccc(cc1)N1CCC[C@@H](NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O |r|
Show InChI InChI=1S/C26H31F3N4O3/c1-36-17-22-5-2-3-15-32(22)20-11-13-21(14-12-20)33-16-4-6-23(24(33)34)31-25(35)30-19-9-7-18(8-10-19)26(27,28)29/h7-14,22-23H,2-6,15-17H2,1H3,(H2,30,31,35)/t22?,23-/m1/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 2.10n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)

More data for this
Ligand-Target Pair